Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

Leukemia, Lymphocytic, Acute

OHSU Knight Cancer Institutemonoclonal_antibodyPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Leukemia, Lymphocytic, Acute cohort.

Asset / SponsorPhaseRating
Equine Atg
Instituto Nacional de Cancer, Brazil
Phase 3BBB
INTERFERON-ALFA-2A
French Innovative Leukemia Organisation
Phase 3BB
TRASTUZUMAB
OHSU Knight Cancer Institute
Phase 2B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
M.D. Anderson Cancer Center
Phase 2B
Cart-19 Cells
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1/2CCC

View all 15 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:

breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →
inflammatory breast carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
HER2 positive breast carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →